Nisa Investment Advisors, LLC Chinook Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$18.66 - $38.58 $13,621 - $28,163	730 Added 77.33%	1,674 $64,000
Q3 2022 Nov 07, 2022	BUY	$17.51 - $23.37 $735 - $981	42 Added 4.66%	944 $20,000
Q2 2022 Aug 03, 2022	BUY	$12.59 - $18.8 $7,176 - $10,716	570 Added 171.69%	902 $16,000
Q1 2022 Apr 29, 2022	SELL	$12.02 - $16.69 $1,682 - $2,336	-140 Reduced 29.66%	332 $5,000
Q4 2020 Jan 25, 2021	SELL	$11.9 - $20.91 $10,567 - $18,568	-888 Reduced 65.29%	472 $7,000
Q3 2020 Oct 20, 2020	BUY	$11.4 - $15.5 $15,504 - $21,080	1,360 New	1,360 $3,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.